These results align with prior reports demonstrating that EtOH enhances EGR1 expression and nuclear translocation, which have been implicated in inhibiting osteogenic differentiation of bone marrow mesenchymal stem cells and promoting chronic EtOH-induced hepatic steatosis [53,54]. The gene discussed is EGR1; the disease is fatty liver disease.